Yatharth Hospital And Trauma Care Services Limited · NSE:YATHARTH

Yatharth Hospital And Trauma Care Services — Q2 FY24 Earnings Presentation

40 slides from Yatharth Hospital And Trauma Care Services's earnings presentation, Nov 7, 2023

  1. Slide 1: Cover letter to stock exchanges

    November 7, 2023 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 P J Towers, Dalal Street, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai -400001, India Mumbai – 400 051 Symbol: YATHARTH Scrip Code: 54

  2. Slide 2: Q2 & H1 FY24 Earnings Presentation

    www.yatharthhospitals.com Q2 & H1 FY24 Earnings Presentation November 7, 2023 1

  3. Slide 3: Disclaimer

    Disclaimer Certain matters discussed in this Presentation may contain statements regarding the company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements doesn’t guarantee future performance and are subject t

  4. Slide 4: Q2 & H1 FY24 Performance Highlights

    Q2 & H1 FY24 Performance Highlights 3

  5. Slide 5: Q2 & H1 FY24 Financial Highlights

    Q2 & H1 FY24 Financial Highlights Q2 H1 Rs. 1,713 mn +34% YoY Rs. 3,258 mn +11% QoQ +36% YoY Revenue Margin Rs. 456 mn Margin Rs. 870 mn 26.6% +36% YoY +47% YoY 26.7% +40bps YoY +10% QoQ EBITDA +192bps YoY Margin Rs. 276 mn Margin Rs. 466 mn 14.3% 16.1% +70% YoY +71% YoY +345bps YoY +45% QoQ PAT +29

  6. Slide 6: Financial Highlights

    Financial Highlights Revenue (Rs mn) EBITDA (Rs mn) & EBITDA% +34% +36% 26.8% 26.7% 3,258 26.2% 26.6% 1000 27% 99 5 99 0 1000 27% 98 5 99 5 98 0 24.8% 99 0 975 +11% 98 5 970 98 0 96 5 26% 975 96 0 970 95 5 96 5 26% 95 0 96 0 94 5 95 5 94 0 95 0 935 94 5 930 94 0 925 25% 935 920 930 915 925 25% 910 9

  7. Slide 7: Strengthened Balance Sheet

    Strengthened Balance Sheet Equity Base Expansion (Rs mn) 40% Debt Repayment – 2,450 mn 8,065 Organic Capex – 1,326 mn 22% Rs 6,100 mn IPO Proceeds 11% 1,830 Inorganic Expansion – 650 mn 27% General Corporate & Issue Mar-23 Sep-23 Exps. – 1,674 mn Debt Repayment (Rs mn) 2,674 Ongoing Capex (Rs mn) Ca

  8. Slide 8: Operational Highlights

    Operational Highlights ❑ Occupancy increases to 57% in Q2FY24, vs 45% in Q2FY23 and 50% in Q1FY24; Noida and Greater Noida hospital reported highest occupancy levels of 96% and 73% respectively during the quarter ❑ Inpatient revenue up by 37% YoY during the quarter, and 40% YoY during the half-year

  9. Slide 9: Operational KPIs

    Operational KPIs IPD & OPD Revenue (Rs mn) IPD & OPD Volumes (in ‘000s) IPD Revenue OPD Revenue IPD Volume OPD Volume 3,258 188 185 1,713 2,389 410 101 1,545 97 89 1,279 224 352 186 192 166 161 2,848 89 84 1,489 77 1,359 2,037 1,087 12 12 13 22 24 Q2FY23 Q1FY24 Q2FY24 H1FY23 H1FY24 Q2FY23 Q1FY24 Q2F

  10. Slide 10: Operational KPIs: Occupancy

    Operational KPIs 3,258 Revenue (Rs mn) 2,389 1,545 1,713 1,279 1,172 949 825 953 971 497 444 559 465 443 613 488 529 585 317 162 21 79 83 30 Q2FY23 Q1FY24 Q2FY24 H1FY23 H1FY24 ARPOB (Rs) 33,926 33,181 32,581 31,136 30,394 28,140 27,833 27,561 26,302 26,168 25,799 25,691 25,589 24,648 24,605 20,232 1

  11. Slide 11: Our Specialties

    Our Specialties Diversified specialty services H1 FY24 Mix (%) 2023 31% 10% 10% 9% 9% 6% 5% 5% 4% 3% 9% Cardiology 10% Internal Nephrology & Medicine 2022 50% urology, 10% 33% Neurosciences 9% Oncology, 3% 2021 56% Gynecology, 4% General surgery, 7% Gastroenterology, 4% Others*, 6% 0% 10% 20% 30% 40

  12. Slide 12: Clinical Achievements

    Y Clinical Achievements a] TRANSPLANTS AT YATHARTH Wife gives new lease of life to husband by donating her kidney NEW ANGIOPLASTY TECHNIQUE AT YATHARTH SAVES 91-YEAR- OLD First Successful By Dr. Kanuj Malik (Surgical Oncologist) & Yatharth Hospitals Specialist Team Yatharth Hospital organized WALKAT

  13. Slide 13: Profit & Loss Summary

    Profit & Loss Summary Change Change Change Particulars (Rs Mn) Q2FY24 Q2FY23 Q1FY24 H1FY24 H1FY23 YoY QoQ YoY Revenue from Operations 1,713 1,279 34% 1,545 11% 3,258 2,390 36% Medical Consumables & 360 231 56% 281 28% 641 444 44% Pharmacy items Employee Expenses 284 237 20% 268 6% 552 433 27% Other

  14. Slide 14: Balance Sheet

    Balance Sheet Particulars (Rs Mn) Sep-23 Mar-23 Particulars (Rs Mn) Sep-23 Mar-23 Shareholders Equity 8,065 1,830 Fixed Assets (including Goodwill) 2,925 2,950 Borrowings 105 2,638 Right to Use Assets 25 35 Lease Liabilities 26 36 Financial Assets 16 20 Trade Payables 146 169 Inventories 59 61 Other

  15. Slide 15: About The Company

    About The Company 14

  16. Slide 16: At a Glance

    At a Glance Leading super specialty hospital in Delhi-NCR Among top 10 largest private hospitals One-stop destination for patient needs providing all of Delhi NCR region in terms of number levels of healthcare services from primary to tertiary of beds 2019 Noida Extension 4 10 1,405 Hospitals Center

  17. Slide 17: Our Journey

    Our Journey Growing presence across regions and services 2008 2013 2019 2023 Incorporation of Established our Commencement of Listing on NSE & BSE company and second 250 bedded our third hospital, commencement of hospital, in Noida Noida Extension operations hospital, in May 2019, pursuant to the ac

  18. Slide 18: Greater Noida Hospital Overview

    Greater Noida Hospital Overview Revenue from Operations (Rs mn) Provides a wide spectrum of super specialty services in the field of 1,994 cardiology, cardiovascular and thoracic surgery, neurology, neurosurgery, 1,702 urology, nephrology, oncology, gastroenterology etc. 1,172 949 Strategy to develo

  19. Slide 19: Noida Hospital Overview

    Noida Hospital Overview Revenue from Operations (Rs mn) Provides services across 30 specialties, including cardiac sciences, 1,721 orthopedics, nephrology, urology, neurosciences, gastroenterology, etc. 1,283 953 825 Strategy to improve ALOS and improve the combination of super 681 specialties, for

  20. Slide 20: Noida Extension Hospital Overview

    Noida Extension Hospital Overview Revenue from Operations (Rs mn) Plan to develop this hospital as a Centre of Excellence for oncology treatment and robotic surgeries 1,357 1,023 971 Plan to start liver transplant operations; recently started bone marrow and 795 585 kidney transplant operations. Rad

  21. Slide 21: Jhansi – Orchha Hospital Overview

    Jhansi – Orchha Hospital Overview Revenue from Operations (Rs mn) One of the largest hospital in Jhansi-Orchha-Gwalior region, has 162 infrastructure to operate all the major super specialties 131 Acquired in FY22, aimed at further expanding into new geographies and growing presence in the regional

  22. Slide 22: Our Specialties

    Our Specialties Expanding share of high value specialties Revenue change - FY23 vs FY21 30 Specialties and FY21-23 CAGR 13% 66% 77% 72% 82% 65% 79% 108% 131% 209% 53% Super specialties including 10 Centers of FY2021 FY2023 Excellence (COE) Revenue (Rs. mn) Our COEs ➢ Centre of Internal Medicine 1,63

  23. Slide 23: Payer mix

    Payer mix Balanced revenue split between payer categories Self-payers FY2023 1,888 1,605 885 FY21 FY22 FY23 Self-payers Central, state and others and local Insurers through TPA 36% government 1,227 1,381 bodies 669 under government scheme FY21 FY22 FY23 37% Insurers acting through third party Govern

  24. Slide 24: Our Strengths

    \f 23 OUR STRENGTHS

  25. Slide 25: Strengths

    Strengths Among the leading super-specialty hospital Regional advantage in Delhi NCR Advanced and high-end medical Experienced and professional equipment and technology management team Track record of stable Team of highly qualified operating & financial medical professionals performance 24

  26. Slide 26: Leading hospital in Delhi NCR, attracts patients from adjoining states

    Leading hospital in Delhi NCR, attracts patients from adjoining states with inadequate healthcare facilities 2 of Yatharth’s hospitals are amongst top 10 largest private Delhi NCR region hospitals in Delhi NCR* Jhansi-Orchha- ➢ Noida, Greater Noida and Noida extension attract patients from the Gwali

  27. Slide 27: Regional Advantage

    Regional Advantage Integrating talent from First mover advantage in well-established allied building out network workforce across Tier II/III cities Promoters being Stronger local connect doctors, have better with people 26 connect with doctors

  28. Slide 28: Advanced and high-end medical equipment and technology

    Advanced and high-end medical equipment and technology • Hospitals are equipped with machines and devices with sophisticated technology • Strive to introduce cutting-edge medical technology and state-of-the-art equipment • Catheterization Laboratory Diagnostic Certifications • Computerized Tomograph

  29. Slide 29: Team of highly qualified medical professionals

    Team of highly qualified medical professionals Number of Doctors (Sep’23) Full Time Employees (Sep’23) Paramedical, Nursing, 877 398 Visiting Specialist Resident Doctors, 164 Doctors, 253 Medical Resident Doctors, 224 Corporate and Medical Support Staff, Specialist Doctors, 224 1,823 Doctors, 253 At

  30. Slide 30: Experienced and professional management team

    Experienced and professional management team Leadership Promoted by experienced medical professionals, Dr. Ajay Kumar Tyagi and Dr. Kapil Kumar Dr. Ajay Kumar Tyagi Dr. Kapil Kumar Chairman & Whole-time Director Managing Director Management Led by experienced and qualified professional management te

  31. Slide 31: Track record of stable operating and financial performance

    Track record of stable operating and financial performance Growth led by strong operational Optimizing Capex Allocation 1. Stable operating & efficiency: 1. Reinvesting in increasing bed financial performance 1. Streamlining clinical and capacity and opening new hospitals 2. Continued growth over th

  32. Slide 32: Growth Strategy

    Growth Strategy Continue to Introduce new Grow medical Augment scale Further leverage improve our specialties at tourism segment through organic technology to quality of care existing hospitals to attract and inorganic grow operations and operational international manner in current efficiencies pati

  33. Slide 33: Key Growth Drivers (1/2)

    Key Growth Drivers (1/2) Improving specialty mix Introduce new specialties at Grow medical tourism segment towards high value specialties existing hospitals to attract international patients ➢ Increase in share of higher value ➢ Noida Extension taking the lead by ➢ Close proximity to the upcoming sp

  34. Slide 34: Key Growth Drivers (2/2)

    Key Growth Drivers (2/2) Leverage technology to grow Improving utilization & Jhansi Targeting Balanced Growth operations hospital stabilization ➢ Augment scale through organic ➢ Adopt the latest medical ➢ Focus towards increasing ARPOB and inorganic manner in current technologies and equipment to an

  35. Slide 35: Appendix

    Appendix 34

  36. Slide 36: Board of Directors (1/2)

    Board of Directors (1/2) Dr. Ajay Kumar Tyagi Dr. Kapil Kumar Yatharth Tyagi Chairman & Whole-time Director Managing Director Whole-time Director ➢ Over 17 years of experience in medical ➢ Over 17 years of experience in medicine ➢ Associated with the company since 2019 care and hospital management a

  37. Slide 37: Board of Directors (2/2)

    Board of Directors (2/2) Promila Bhardwaj Mukesh Sharma Sanjeev Upadhyaya Independent Director Independent Director Independent Director ➢ Over 35 years of experience in public ➢ Over 35 years of experience in banking ➢ Over 20 years of experience in administration ➢ Previously associated with Bank

  38. Slide 38: Management Team

    Management Team Amit Kumar Singh Pankaj Prabhakar Deepak Kumar Tyagi Chief Executive Officer Chief Financial Officer President, Strategy and Finance ➢ Over 17 years of experience in hospital ➢ Over 16 years of experience incorporate ➢ Approximately 14 years of experience management finance of severa

  39. Slide 39: Shareholding Pattern

    Shareholding Pattern Shareholding Pattern* BSE Ticker 543950 19.18% NSE Ticker YATHARTH 5.42% 9.07% Market Capitalization* 66.33% Rs. 32,434 mn No. of shares outstanding 8,58,50,233 Promoter Group DIIs FIIs Others 38 * As on September 30, 2023

  40. Slide 40: Thank You

    Thank You www.yatharthhospitals.com Yatharth Hospital & Trauma Care Services Ltd CIN: L85110DL2008PLC174706 www.yatharthhospitals.com Investor Relations investor.relations@yatharthhospitals.com 39

Yatharth Hospital and Trauma Care Services — Q2 FY24 Earnings Presentation on 6ix